drug price negotiations as it seeks to lower medical costs for Americans. Other drugs on the list include AstraZeneca's diabetes and
WILMINGTON, Del.The U.S. Food and Drug Administration has approved AstraZeneca's QTERN for the treatment of type 2 diabetes.
ONGLYZA, an investigational drug under joint development by Bristol-Myers Squibb and AstraZeneca for the treatment of type 2 diabetes, was
About AstraZeneca in Diabetes AstraZeneca is pushing the boundaries of science with the goal of developing life-changing medicines that aim to reduce the global burden and complications of diabetes. Our commitment to diabetes is exemplified by the depth and breadth of our global clinical research program.
Medications that prevent blood clots and help with diabetes are among the first 10 drugs AstraZeneca, a drug manufacturer based in the
The Eccogene drug is currently in Phase 1 testing in healthy volunteers and patients with type 2 diabetes. According to AstraZeneca
AstraZeneca drug that is considered standard of care. Biohaven Patients with diabetes are now less able to access life-saving drugs
CDSCO approves AstraZeneca's anti-diabetic drug Dapagliflozin with additional indications AstraZeneca India has received the Central Drugs
drug for Type 2 diabetes treatment, enhancing glycaemic control in diabetic patients. In October 2024, AstraZeneca India launched a Clinical Data and
Comments